Phanes came to Axxiem for a redesign that would provide them a world-class presence highlighting their important work in the area of bispecific antibodies as well as their two unique technologies: PACbody and ATACCbody.
Phanes Therapeutics is a startup led by a team of industry veterans with extensive drug discovery and development experience in global pharma and biotech companies, including Pfizer, Amgen, and J&J.


